Video | TCTAP 2024

[Clinical Science] Ongoing Trials from Asan Medical Center

April 27, 2024 / 11:30 AM ~ 12:40 PM 📌 Presentation Room 1, Level 1

Moderator(s): William F. Fearon, Byeong-Keuk Kim
Panelist(s): Junya Ako, Dominick J. Angiolillo, Jang-Whan Bae, Ho Lam, Kambis Mashayekhi, Nicolas Van Mieghem

• TAILORED-CHIP Trial: Temporal Dynamic Antiplatelet Strategy for Complex High-Risk PCI
  Hanbit Park
• ENAVO-TAVR Trial: SGLT-2 Inhibitor for Post-TAVR
  Jinho Lee
• DEFINE-DM Trial: Imaging- and Physiology-guided State-of-the Art PCI vs. CABG for DM and Multi-Vessel Disease
  Hoyun Kim
• FATE-MAIN Trial: FFR- vs. Angiography-guided Left Main PCI
  Jung-Min Ahn
• Panel Discussion l
• EPIC-CAD Trial: Long-Term Antithrombotic Strategy in AF Patients With Stable CAD
  Gi-Byoung Nam
• PROTECT-HBR Trial: New GI Protection Drug for High-Bleeding Risk Patients Requiring Antithrombotic Agents - P-CAB vs. PPI
  Jinho Lee
• ASSURE-DES Trial: Optimal Antiplatelet Strategy in DES Patients During Noncardiac Surgery
  Hanbit Park
• VARIANT-ICD Trial: ICD vs. Medical Therapy Alone in Variant Angina With Aborted SCD
  Jung-Min Ahn
• Panel Discussion ll